SynthesisJournal of medical virology2021

The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.

Yixuan Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.